Abstract
Recurrence after surgical removal of parotid pleomorphic salivary adenoma using retrograde
facial nerve dissection is not well researched. We adopted retrograde nerve dissection
for parotid surgery for benign disease as a standard procedure in 1995. The objective
of this study was to establish the rate of recurrence of primary tumours associated
with the technique after removal of parotid pleomorphic salivary adenoma. We recruited
59 patients over a 16-year (1995–2011) period and collected the data prospectively.
Eight patients were excluded as they had died or had been lost to follow up. Male:female
ratio was 16:35 and age range was 15–69 years. The mean tumour size as measured on
magnetic resonance imaging (MRI) was 27.4 mm. Thirty-eight patients had superficial parotidectomy, 8 had total parotidectomy,
and 5 had partial superficial parotidectomy. Mean follow up from the date of operation
was 104 months (median 98, range 17–171). All patients were reviewed and examined
in 2011 to establish whether the tumour had recurred. One patient had developed a
solitary nodular recurrence 8 years after the initial procedure. Recurrence was 2%.
The rate of clinically apparent recurrence after parotidectomy for pleomorphic salivary
adenoma in this study is low and is comparable with others reported.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to British Journal of Oral and Maxillofacial SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise.Br J Cancer. 2003; 89: 1610-1613
- Current management of benign parotid tumours—the role of limited superficial parotidectomy.Head Neck. 2003; 25: 946-952
- Malignant tumours of the major salivary glands.in: DeBurgh Norman J.E. McGurk M. Color atlas and text of the salivary glands: diseases, disorders and surgery. Mosby-Wolfe, London1995: 173
- The surgical approaches to the treatment of parotid pleomorphic adenomas.in: McGurk M. Renehan A. Controversies in the management of salivary gland disease. Oxford University Press, Oxford2001: 57-66
- Conservative parotidectomy by the peripheral approach.Br J Surg. 1981; 68: 405-407
- Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions.Clin Otolaryngol Allied Sci. 2003; 28: 262-266
- The significance of the margin in parotid surgery for pleomorphic adenoma.Laryngoscope. 2002; 112: 2141-2154
- Facial nerve grading systems.Laryngoscope. 1983; 93: 1056-1069
- Assessing recovery of facial function following acoustic neuroma surgery.Otolaryngol Head Neck Surg. 1984; 92: 88-93
- Facial nerve grading system.Otolaryngol Head Neck Surg. 1985; 93: 146-147
- Techniques for dissection of the facial nerve in benign parotid surgery: a cross specialty survey of oral and maxillofacial and ear nose and throat surgeons in the UK.Br J Oral Maxillofac Surg. 2008; 46: 564-566
- An objective assessment of the advantages of retrograde parotidectomy.Otolaryngol Head Neck Surg. 2004; 131: 392-396
- Superficial parotidectomy through retrograde facial nerve dissection.J R Coll Surg Edinb. 2001; 46: 104-107
- Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25 year experience with 229 patients.Laryngoscope. 1994; 104: 1487-1494
- Randomised clinical trial comparing partial parotidectomy versus superficial or total parotidectomy.Br J Surg. 2007; 94: 1081-1087
- Facial nerve morbidity after retrograde nerve dissection in parotid surgery for benign disease: a 10-year prospective observational study of 136 cases.Br J Oral Maxillofac Surg. 2007; 45: 101-107
- A modified centripetal approach to parotidectomy.J Oral Maxillofac Surg. 1985; 43: 14-19
- Parotid tumours—pertinent papers 2002–2003: a personal view.Br J Oral Maxillofac Surg. 2005; 43: 350-353
- Extracapsular dissection–minimal resection for benign parotid tumours.Br J Oral Maxillofac Surg. 2011; ([Epub ahead of print] PMID 21215499)
- The significance of the tumour capsule in pleomorphic adenoma.in: McGurk M. Renehan A. Controversies in the management of salivary gland disease. Oxford University Press, Oxford2001: 67-79
- Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas.Br J Surg. 1996; 83: 1747-1749
- Recurrent pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia.Cancer. 1998; 82: 617-620
Article info
Publication history
Published online: August 31, 2011
Accepted:
August 10,
2011
Identification
Copyright
© 2011 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
